Again, cranberries have been cleared. Perhaps this post will put that case to bed:
Additional evidence has been presented showing the safe use of cranberry products for patients on Coumadin
An article appearing in the Journal of Health-System Pharmacist again evaluated the use of cranberry products and concluded the following:
Reports from the United Kingdom have raised concern over the interaction potential between cranberry juice and warfarin. Warfarin is the most commonly prescribed oral medication for anticoagulation therapy. Cranberry juice is a flavonoid, which has been shown to induce, inhibit, or act as a substrate for the biosynthesis of several cytochrome P-450 (CYP) isoenzymes. Specifically, cranberry juice may inhibit the activity of CYP2C9, the primary isoenzyme involved in the metabolism of S-warfarin. A search of the medical literature identified three peer-reviewed case reports and two peer-reviewed, prospective, randomized, placebo-controlled clinical trials using metabolic surrogates of warfarin (flurbiprofen and cyclosporine) that described possible interactions between cranberry juice and warfarin. Two case reports suggested that cranberry juice increased the International Normalized Ratio (INR) of patients taking warfarin, but neither clearly identified cranberry juice as the sole cause of INR elevation. One case report appeared to show a correlation between the effects of cranberry juice and warfarin metabolism. Both clinical trials indicated the lack of an interaction between cranberry juice and CYP isoenzymes 2C9 and 3A, both of which are necessary in warfarin metabolism. More studies are required to determine the potential interaction between cranberry juice and warfarin (Coumadin ®).
The available data do not seem to show a clinically relevant interaction between cranberry juice and warfarin; however, patients taking warfarin with cranberry juice should be cautioned about the potential interaction and monitored closely for INR changes and signs and symptoms of bleeding.
American Journal of Health-System Pharmacy, Vol. 64, Issue 5, 490-494
Researchers at Tufts University researched cranberry extensively last year and gave cranberry the all clear to be used with patients taking warfarin.
The 2007 Anticoagulation Forum’s national meeting focused an educational seminar on dietary interactive products - including cranberries. Ann Wittkowsky, Clinical Professor [University of Washington School of Pharmacy, Seattle, Washington] led the discussion clearing the safe use of cranberry products, under normal consumption. Dr. Wittkowsky referenced a well designed, double cross-over study (Journal American Dietary Association 2006: 106-2057-61). The study conclusion re-affirmed no interactions were detected and cranberry products do not need to be avoided provided consumption was routine.
Another article:
http://warfarinfo.com/cranberry.htm